Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02715739
Other study ID # mattias-attergrim-201603131327
Secondary ID
Status Completed
Phase N/A
First received March 13, 2016
Last updated February 26, 2017
Start date January 2016
Est. completion date January 2017

Study information

Verified date February 2017
Source Karolinska Institutet
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study aims to compare the predictive performance of two different approaches of the international classification of disease injury severity score (ICISS) using data from four public university hospitals in urban India.


Description:

Research question Is there a difference in the mortality prediction performance of two ICISS approaches for trauma patients admitted to hospitals in urban India?

Study design The investigators will conduct a retrospective registry based study.

Setting The data that will be used is from a prospective cohort study named towards improved trauma care outcomes in India (TITCO). It was collected from four public university hospitals in India between October 2013 and January 2015. The hospitals are in Mumbai, Delhi and Kolkata. The two centers in Mumbai were King Edward Memorial Hospital and Lokmanya Tilak Municipal General Hospital. The one in Delhi was Jai Prakash Narayan Apex Trauma Center and the one in Kolkata was the Institute of Post-Graduate Medical Education and Research and Seth Sukhlal Karnani Memorial Hospital.

The data was collected by one trained project officer at each hospital, working eight-hour shifts with a rotating schedule between day, evening and night shifts. Data from patients admitted outside of the shift hours was collected retrospectively within days of arrival to hospital. The patients were followed until discharge, death or to a maximum of 30 days. If discharged, the patients were considered to be alive at 30 days. There was no follow-up after patient discharge or after the 30 days.

Source and method of participant selection Project officers included consecutive patients that presented to participating hospitals. Patients were included either by direct observation during the project officers' shifts or by retrospective data extraction from patient records.

Data sources/ measurement Patient mortality data was extracted from patient records, as was data on all covariates. If covariate data was missing in records an attempt was made to retrieve this data from the patient or patient relatives. The injury data was extracted from patient records, including imaging reports and intraoperative findings. Protocols from post-mortem examinations were not available. Injuries will be coded using ICD-10. The SRR for an ICD-code will be calculated by dividing the number of fatal outcomes for each ICD-code by the total number of patients with that ICD-code. This results in a number from 0 to 1 that is interpreted as the patient survival ratio.

For example, if 65 out of 100 patients with a given ICD-code survived the SRR for that code would be 0,65. That would mean 65% of the patients with that ICD code survived. In this study, the SRRs used for ICISS calculations were taken from a publicly available SRR-set calculated from the TITCO dataset (TO BE RELEASED). The ICISS for each patient will then be calculated using two different approaches. The cICISS will be calculated as the product of all of the patient's SRRs. The swiICISS will be equal to the patient's lowest SRR. Both ICISS methods result in a number that ranges from 0 to 1 that should be interpreted as the patient specific probability of survival.

Bias The project officers were trained by project management. They were not involved in patient care and only acquired data by observing hospital staff, using patient records or from patient relatives. All project officers had at least a health science master's degree and were continuously supervised by project management. Injury coders will be blinded to patient demographics and mortality data during the conversion from free-text injuries to ICD-codes and will be trained prior to the ICD-10 coding using the World Health Organization (WHO) ICD-10 online training module. They will gain access to the injury dataset first after reaching 80% agreement in several samples of 50 injuries compared to an external coder.

Study size The sample size calculation is based on published recommendations on effective sample sizes needed to validate prediction models. These recommendations are based on simulations of the sample sizes needed to detect statistically significant differences in predictive performance measures between two scores setting the power to 80% and the significance level to 5%. Hence, the required sample size was calculated to include the most recent 200 consecutive events, i.e. patients who died within 24 hours, and all non-events enrolled during the same time period. Mortality within 24 hours for was used for the sample size calculation as the investigators wanted the study to be powered for secondary outcomes also.

Quantitative variables All quantitative variables will be analyzed as continuous.

Statistical methods and analyses The investigators will use R for all statistical analyses. Predictive performance will be assessed in terms of discrimination and calibration. Discrimination will be assessed by calculating the area under the receiver operating characteristics curve (AUROCC) and calibration will be assessed by comparing observed and predicted outcomes visually in a calibration plot and statistically by calculating the calibration slope. Confidence intervals for predictive performance measures will be estimated using a bootstrap approach (15).

Overlapping confidence intervals will be interpreted as evidence of lack of a statistically significant difference. Parametric and non-parametric exact tests will be used as appropriate, with 95% confidence intervals and a 5% significance level. The main analysis will be a complete case analysis, in which observations with missing values in any of the following variables will be excluded: time of arrival, age, sex, mechanism of injury, transfer status, and outcome variables. Observations with no injuries reported will be assigned ICISS scores of 1 and for each observation the final ICISS scores will be calculated based only on SRRs for ICD-codes that occur at least ten times in the published SRR-set used in this study.

The published SRR-set includes SRRs based on both mortality within 30 days, henceforth referred to as SRR-30D, and SRRs based on mortality within 24 hours, henceforth referred to as SRR-24H. The investigators will use these SRRs to calculate cICISS and swiICISS for each patient, henceforth referred to as cICISS-30D, cICISS-24H, swiICISS-30D and swiICISS-24H. Finally, the investigators will assess and compare the performance of cICISS-30D and swiICISS-30D in predicting mortality within 30 days and within 24 hours, and repeat this analysis for cICISS-24H and swiICISS-24H.

Sensitivity analyses Four sensitivity analyses will be conducted. In the first sensitivity analysis the investigators will only include observations with complete outcome data, however missing values in covariates were allowed. In the second sensitivity analysis the investigators will exclude observations without any reported injury. In the third sensitivity analysis the investigators calculated cICISS and swiICISS based on all available SRRs, regardless of how frequently the corresponding ICD-10 codes occurred in the dataset. Finally, the investigators calculated the two ICISS scores for each patient based only on unique ICD-10 codes. In other words, each ICD-10 code was only allowed to contribute with one SRR to the ICISS scores even if it occurred more than once in the same patient.


Recruitment information / eligibility

Status Completed
Enrollment 3921
Est. completion date January 2017
Est. primary completion date January 2017
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion criteria

- All admitted patients that presented with history of trauma and were alive at arrival to any of the studied hospitals.

- Patients who died after arrival but before admittance were also included.

Exclusion criteria

- Eligible patients with isolated limb injury, i.e. isolated extremity fractures without vascular injury were not included.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
No intervention


Locations

Country Name City State
n/a

Sponsors (6)

Lead Sponsor Collaborator
Karolinska Institutet Jai Prakash Narayan Apex Trauma Center, King Edward Memorial Hospital, Lokmanya Tilak Municipal General Hospital, Seth Sukhlal Karnani Memorial Hospital, Tata Institute of Social Sciences

Outcome

Type Measure Description Time frame Safety issue
Primary Mortality Within 30 days of patient arrival to participating centre
Secondary Mortality Within 24 hours of patient arrival to participating centre
See also
  Status Clinical Trial Phase
Recruiting NCT04554212 - Blood Flow Restriction Training After Patellar INStability N/A
Suspended NCT02932176 - Machine Learning for Handheld Vascular Studies
Recruiting NCT04803253 - Study of the Social and Professional Reintegration Improvements Using a Set of Solutions for Upper Limb Amputation N/A
Completed NCT00116337 - Spinal Cord Stimulation to Restore Cough N/A
Completed NCT03463720 - Outcome for Patients With War-Associated Extremity Wound Infection N/A
Completed NCT03113253 - TRANexamic Acid to Reduce Bleeding in BURN Surgery Phase 4
Not yet recruiting NCT05492903 - COMmunity of Practice And Safety Support for Navigating Pain (COMPASS-NP) N/A
Terminated NCT02909231 - One-year Patient Reported Outcomes Following Hospitalization for Trauma N/A
Completed NCT02432456 - Ketamine Infusion Therapy for the Management of Acute Pain in Adult Rib Fracture Patients Phase 4
Completed NCT02266771 - Impact of V.A.C. Veraflo Therapy in Wounds Requiring Debridement Within an Orthopedic Practice N/A
Completed NCT02744144 - Wound Bacterial Microbiota and Their Antibiotic Resistance N/A
Completed NCT02394821 - Odor Management in Fungating Wounds Comparing Metronidazole and Polihexanide Phase 3
Not yet recruiting NCT01665963 - Efficacy of TopClosure(C)System in Healing Complicated Pacemaker Wounds N/A
Completed NCT00151112 - Comparison of Two Different Procedures for Plexus Anesthesia N/A
Not yet recruiting NCT03872544 - Short Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
Recruiting NCT04596124 - Effectiveness and Tolerability of Fitostimoline Plus Cream and Gauze vs Connettivina Bio Plus Cream and Gauze N/A
Recruiting NCT05800834 - Benefits of Morphine Gel for Pain Reduction in Patients With Cancer Wounds Phase 2
Enrolling by invitation NCT03880188 - Long Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
Terminated NCT04775316 - Prospective, International, Multicenter, Observational Study to Evaluate the Clinical Performance and Safety of a Silicone-coated Transparent Postoperative Dressing
Enrolling by invitation NCT03312504 - Implementing a School Prevention Program to Reduce Injuries Through Neuromuscular Training N/A